Short Description
Middle East and Africa Lab Automation Market, By Product Type (Equipment, Software & Informatics, Analyzer), Automation Type (Modular Automation, Total Lab Automation), Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Bio Analysis, Protein Engineering, Lyophilization, System Biology, Analytical Chemistry), End Users (Biotechnology & Pharmaceuticals, Hospitals & Laboratories, Research and Academic Institutions, and Others), Countries (South Africa, Ethiopia, UAE, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Definition:
Laboratory automation is the combination of automated technologies in the laboratory to enable new and improved processes. It is used as a strategy to research, develop, optimize and capitalize on technologies in the laboratory. It is specially used for automating laboratory processes requiring minimal human input and eliminating human error. Lab automation is used with the aim of providing more efficient testing and diagnostics.
Lab automation enables researchers and technicians to efficiently and effectively produce output in less time, which is expected to drive the lab automation market. Furthermore, the rapid spread of diseases, along with new discoveries in the field of healthcare, ascend the demand for diagnoses and treatments, which is expected to fuel the lab automation market. High government and private funding for research and discovery research and the presence of major market players also contribute to the market growth.
Market Segmentation:
Middle East and Africa lab automation market is categorized into four notable segments such as product type, automation type, application, and end users.
On the basis of product type, the Middle East and Africa lab automation market is segmented into equipment, software & informatics, and analyzer
On the basis of automation type, the Middle East and Africa lab automation market is segmented into modular automation and total lab automation
On the basis of application, the Middle East and Africa lab automation market is segmented into drug discovery, clinical diagnostics, genomic solutions, proteomic solutions, bio analysis, protein engineering, lyophilization, system biology, analytical chemistry, and others
On the basis of end users, the Middle East and Africa lab automation market is segmented into biotechnology & pharmaceuticals, hospitals & laboratories, research and academic institutions, and others
Market Players
Some of the key market players in the Middle East and Africa lab automation market are listed below:
Danaher
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN
F. Hoffman-La Roche Ltd
Siemens Healthcare GmbH
Abbott
Aurora Biomed Inc.
BD
BIOMRIEUX
Eppendorf SE
LabVantage Solutions Inc.
LabWare
TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA LAB AUTOMATION MARKET 29
1.4 LIMITATIONS 31
1.5 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 PRODUCT TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET END USER COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTERS FIVE FORCES 49
5 REGULATION 50
6 MARKET OVERVIEW 52
6.1 DRIVERS 54
6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 54
6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 54
6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 54
6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 55
6.2 RESTRAINTS 55
6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 55
6.2.2 HIGH COST FOR INSTALLATION AND SETUP 55
6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 56
6.3 OPPORTUNITIES 56
6.3.1 RISING HEALTHCARE EXPENDITURE 56
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 57
6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 57
6.4 CHALLENGES 58
6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 58
6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 58
7 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET, BY PRODUCT TYPE 59
7.1 OVERVIEW 60
7.2 EQUIPMENT 63
7.2.1 AUTOMATED WORKSTATIONS 63
7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 63
7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 63
7.2.1.3 PIPETTING SYSTEMS 64
7.2.1.4 MICROPLATE WASHERS 64
7.2.1.5 REAGENT DISPENSERS 64
7.2.2 MICROPLATE READERS 64
7.2.2.1 MULTI-MODE MICROPLATE READERS 64
7.2.2.2 SINGLE-MODE MICROPLATE READERS 64
7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 64
7.2.2.4 AUTOMATED ELISA SYSTEMS 65
7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 65
7.2.4 ROBOTIC SYSTEMS 65
7.2.4.1 ROBOTIC ARMS 65
7.2.4.2 TRACK ROBOTS 65
7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 65
7.2.6 OTHERS 65
7.3 ANALYZER 65
7.3.1 BIO CHEMISTRY ANALYZERS 66
7.3.2 HAEMATOLOGY ANALYZERS 66
7.3.3 IMMUNO-BASED ANALYZERS 66
7.4 SOFTWARE & INFORMATICS 66
7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 67
7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 67
7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 67
7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 68
8 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET, BY AUTOMATION TYPE 69
8.1 OVERVIEW 70
8.2 TOTAL LAB AUTOMATION 73
8.3 MODULAR AUTOMATION 73
9 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET, BY APPLICATION 74
9.1 OVERVIEW 75
9.2 CLINICAL DIAGNOSTICS 78
9.3 DRUG DISCOVERY 78
9.4 GENOMICS SOLUTIONS 78
9.5 PROTEOMIC SOLUTIONS 79
9.6 ANALYTICAL CHEMISTRY 79
9.7 PROTEIN ENGINEERING 80
9.8 BIO ANALYSIS 80
9.9 SYSTEM BIOLOGY 81
9.10 OTHERS 81
10 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET, BY END USER 83
10.1 OVERVIEW 84
10.2 BIOTECHNOLOGY & PHARMACEUTICALS 87
10.3 HOSPITALS & LABORATORIES 87
10.4 RESEARCH & ACADEMIC INSTITUTES 87
10.5 OTHERS 88
11 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET, BY REGION 89
11.1 MIDDLE EAST AND AFRICA 90
11.1.1 SOUTH AFRICA 98
11.1.2 SAUDI ARABIA 102
11.1.3 U.A.E. 106
11.1.4 REST OF MIDDLE EAST AND AFRICA 110
12 MIDDLE EAST & AFRICA LAB AUTOMATION MARKET: COMPANY LANDSCAPE 111
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 111
13 SWOT ANALYSIS 112
14 COMPANY PROFILE 113
14.1 THERMO FISHER SCIENTIFIC INC. 113
14.1.1 COMPANY SNAPSHOT 113
14.1.2 REVENUE ANALYSIS 114
14.1.3 COMPANY SHARE ANALYSIS 114
14.1.4 PRODUCT PORTFOLIO 114
14.1.5 RECENT DEVELOPMENTS 115
14.2 DANAHER 116
14.2.1 COMPANY SNAPSHOT 116
14.2.2 REVENUE ANALYSIS 116
14.2.3 COMPANY SHARE ANALYSIS 117
14.2.4 PRODUCT PORTFOLIO 117
14.2.5 RECENT DEVELOPMENTS 117
14.3 F. HOFFMANN- LA ROCHE LTD 118
14.3.1 COMPANY SNAPSHOT 118
14.3.2 REVENUE ANALYSIS 118
14.3.3 COMPANY SHARE ANALYSIS 119
14.3.4 PRODUCT PORTFOLIO 119
14.3.5 RECENT DEVELOPMENTS 119
14.4 PERKINELMER INC 121
14.4.1 COMPANY SNAPSHOT 121
14.4.2 REVENUE ANALYSIS 122
14.4.3 COMPANY SHARE ANALYSIS 122
14.4.4 PRODUCT PORTFOLIO 123
14.4.5 RECENT DEVELOPMENTS 123
14.5 BD 124
14.5.1 COMPANY SNAPSHOT 124
14.5.2 REVENUE ANALYSIS 124
14.5.3 COMPANY SHARE ANALYSIS 125
14.5.4 PRODUCT PORTFOLIO 125
14.5.5 RECENT DEVELOPMENTS 125
14.6 ABBOTT 126
14.6.1 COMPANY SNAPSHOT 126
14.6.2 REVENUE ANALYSIS 126
14.6.3 PRODUCT PORTFOLIO 127
14.6.3 RECENT DEVELOPMENTS 127
14.7 AGILENT TECHNOLOGIES 128
14.7.1 COMPANY SNAPSHOT 128
14.7.2 REVENUE ANALYSIS 128
14.7.3 PRODUCT PORTFOLIO 129
14.7.4 RECENT DEVELOPMENTS 129
14.8 AURORA BIOMED INC. 130
14.8.1 COMPANY SNAPSHOT 130
14.8.2 PRODUCT PORTFOLIO 130
14.8.3 RECENT DEVELOPMENTS 130
14.9 AZENTA US INC 131
14.9.1 COMPANY SNAPSHOT 131
14.9.2 REVENUE ANALYSIS 131
14.9.3 PRODUCT PORTFOLIO 132
14.9.4 RECENT DEVELOPMENTS 132
14.10 BIOMERIEUX 133
14.10.1 COMPANY SNAPSHOT 133
14.10.2 REVENUE ANALYSIS 133
14.10.3 PRODUCT PORTFOLIO 134
14.10.4 RECENT DEVELOPMENTS 134
14.11 EPPENDORF SE 135
14.11.1 COMPANY SNAPSHOT 135
14.11.2 PRODUCT PORTFOLIO 135
14.11.3 RECENT DEVELOPMENTS 135
14.12 HAMILTON COMPANY 136
14.12.1 COMPANY SNAPSHOT 136
14.12.2 PRODUCT PORTFOLIO 136
14.12.3 RECENT DEVELOPMENTS 136
14.13 HUDSON ROBOTICS 137
14.13.1 COMPANY SNAPSHOT 137
14.13.2 PRODUCT PORTFOLIO 137
14.13.3 RECENT DEVELOPMENTS 137
14.14 LABLYNX LIMS 138
14.14.1 COMPANY SNAPSHOT 138
14.14.2 PRODUCT PORTFOLIO 138
14.14.3 RECENT DEVELOPMENTS 138
14.15 LABVANTAGE SOLUTIONS INC. 139
14.15.1 COMPANY SNAPSHOT 139
14.15.2 PRODUCT PORTFOLIO 139
14.15.3 RECENT DEVELOPMENTS 139
14.16 LABWARE 140
14.16.1 COMPANY SNAPSHOT 140
14.16.2 PRODUCT PORTFOLIO 140
14.16.3 RECENT DEVELOPMENTS 140
14.17 QIAGEN 141
14.17.1 COMPANY SNAPSHOT 141
14.17.2 REVENUE ANALYSIS 141
14.17.3 PRODUCT PORTFOLIO 142
14.17.4 RECENT DEVELOPMENTS 142
14.18 SIEMENS HEALTHCARE GMBH 144
14.18.1 COMPANY SNAPSHOT 144
14.18.2 REVENUE ANALYSIS 144
14.18.3 PRODUCT PORTFOLIO 145
14.18.4 RECENT DEVELOPMENTS 145
14.19 TECAN TRADING AG 146
14.19.1 COMPANY SNAPSHOT 146
14.19.2 REVENUE ANALYSIS 146
14.19.3 PRODUCT PORTFOLIO 147
14.19.4 RECENT DEVELOPMENTS 147
15 QUESTIONNAIRE 148
16 RELATED REPORTS 151